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Gingival stem cells (GSCs) are recently isolated multipotent cells. Their osteogenic capacity has been validated in vitro and may
be transferred to human cell therapy for maxillary large bone defects, as they share a neural crest cell origin with jaw bone cells.
RT-qPCR is a widely used technique to study gene expression and may help us to follow osteoblast differentiation of GSCs. For
accurate results, the choice of reliable housekeeping genes (HKGs) is crucial. The aim of this study was to select the most reliable
HKGs for GSCs study and their osteogenic differentiation (dGSCs).The analysis was performed with ten selected HKGs using four
algorithms: ΔCt comparative method, GeNorm, BestKeeper, and NormFinder. This study demonstrated that three HKGs, SDHA,
ACTB, and B2M, were the most stable to study GSC, whereas TBP, SDHA, and ALAS1 were the most reliable to study dGSCs. The
comparison to stem cells of mesenchymal origin (ASCs) showed that SDHA/HPRT1were the most appropriate for ASCs study.The
choice of suitable HKGs for GSCs is important as it gave access to an accurate analysis of osteogenic differentiation. It will allow
further study of this interesting stem cells source for future human therapy.
1. Introduction
Gingival stem cells (GSCs) are emerging new tools that
have been recently isolated from human gingival tissue [1],
a tissue with high healing capacity [2]. These cells can
differentiate into osteoblasts, chondrocytes, and adipocytes
when appropriately induced [1, 3]. An easy, noninvasive, and
scar-free access to gingival tissue makes GSCs interesting
cells and a potential source for future regenerative medicine
applications, in order to replace or repair diseased tissues and
organs [2].
Theosteogenic differentiation ofGSCs has been evaluated
in vitro and confirmed using qualitative approaches such as
Alizarin Red S staining [1]. This potential may be used to
treat largemaxillary bone defects. GSCsmay be an alternative
to stem cells derived from mesoderm, because they share
their embryonic origin with facial bones, that is, cephalic
neural crests [4, 5]. In order to better characterize these
cells and their in vitro osteogenic differentiation, molecular
biology quantitative assays can be of high interest, using
gene expression study. This approach is more accurate than
histochemical qualitative methods to study GSCs and con-
firm their stemness and differentiation potencies. To achieve
this purpose, reverse transcription quantitative Polymerase
Chain Reaction (RT-qPCR) technique is considered the most
accurate and reliable method, owing to its sensitivity, real-
time detection of reaction progress, and the amplification of
very small quantities of mRNA [6].
However, reproducibility problems and biases have been
recently discussed [7]. Indeed, many factors may affect the
RT-qPCR accuracy. These are related to operator’s manipu-
lation: pipetting, treating samples, cell culture, the amount
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of starting material, different conditions of harvesting cell
samples, RNA extraction yield, mRNA quality, and homo-
geneity taken from tissues or cells. DNase treatment, reverse
transcription enzyme specificity, the efficiency of reverse
transcription reaction, the type of fluorescence, and the
temperatures of qPCR cycles may also provoke differences
[6].
In order to minimize errors related to these factors,
data normalization is mandatory. Other solutions have been
recently proposed, such as using robots, RNA extraction kits,
or normalized kits from cell culture to cDNA synthesis, which
showed high sensitivity, accuracy, and reproducibility [8].
However, these techniques remain expensive and not accessi-
ble to all research centers. The standardized normalization of
qPCR results against reference genes thus remains the most
commonmethod to have reproducible and reliable results [6].
Reference genes or housekeeping genes (HKGs) are inter-
nal reaction control [9]. It is considered that these HKGs
reflect basic metabolism implicated in the general processes
and mechanisms of cell cycle and hence are supposed not
to be affected or regulated by experimental conditions.
Several criteria are required for a reliable reference gene:
the expression level must be unchanged by experimental
conditions, and its variability must be as minimal as possible
in the different samples. It would be preferable that the cycle
threshold (Ct) of such a HKG is close to the one of the gene
of interest. It is often recommended to use at least two HKGs
or more, because only one may lead to biases or may be
regulated by experimental conditions without the possibility
to control it [6].Thus, HKG choice is a crucial step of the RT-
qPCR protocols, and the investigator must carefully validate
it. However, such information remains often lacking [10].
To avoid mischoices, several statistical approaches and
algorithms have been proposed [11–14]. These methods have
been employed on different mesenchymal stem cells, but to
our knowledge not yet on oral stem cells [15].The objective of
this study is to choose the most reliable HKGs to study GSCs
and their osteoblast differentiation by RT-qPCR. To validate
these HKGs, we will assess the 10 most used HKGs with four
published algorithms: the ΔCt comparative method, GeNorm,
BestKeeper, and NormFinder.
2. Materials and Methods
The study has been carried out thanks to the collaboration
between the Laboratory of Molecular Oral Physiopathology,
INSERM UMRS 1138, Cordeliers Research Center, Paris,
France, and the Hospital Complex Henri-Mondor Albert-
Chenevier, CIC-BT-504, Creteil, France.
Written informed consents were obtained from patients
in accordance with Helsinki Declaration Principles, taking
into account the ethical, legal, and regulatory norms and
standards for research in France (Loi Huriet number 91-73),
as well as the applicable international norms and standards.
Our research protocol was submitted to the research
ethics committee: Centre d’Investigations Cliniques de
Creteil-Henri Mondor (Biothe´rapie) CIC-BT-504, directed
by Pr. Jose´ COHEN, which specifically approved this study.
2.1. Isolation and Growth of Stem Cells: Gingival Stem Cells
(GSCs). GSC cultures were obtained from six healthy donors
(𝑛 = 6), after their informed consent. Gingival tissues
were collected from gingiva of tooth extraction sites from
the donors during surgery. Stem cells were isolated either
by explants technique, followed by fibroblast colony form-
ing units (CFU-F) assay, or by enzymatic digestion with
Collagenase II (Sigma-Aldrich) [16–18]. Eight GSCs samples
were finally obtained (six samples from enzymatic digestion
technique and two samples from explants technique). They
were seeded in 35mm Petri dishes, proliferated with 10mL of
Dulbecco’s Modified Eagle Medium Low Glucose (DMEM-
LG),GlutaMAX, and pyruvate Supplement (Gibco-Life Tech-
nologies, Carlsbad, CA, USA). The medium was supple-
mented with 10% of foetal calf serum (FCS; Gibco), 10mL/L
Penicillin-Streptomycin (5UI/mL,Gibco), 1%of nonessential
amino acids (NEAA;Gibco), and 2.5mg/L ofAmphotericin B
(250 𝜇g/mL; Gibco). Culture medium was filtered in 0.22𝜇m
pore size filters before use. Cell cultures were maintained
at 37∘C in a humidified 5% CO
2
incubator. Culture media
were changed twice a week, with supplementation of L-
Ascorbic Acid 2-Phosphate (50 𝜇g/mL; Sigma-Aldrich), until
they attempted 70 to 80% of confluence. Cells were then
harvested after Trypsin-EDTA treatment and centrifugation.
They were frozen at −80∘C and stored until use for RNA
extraction. GSCs were characterized using flow cytometry
with stem cells markers: CD29, CD73, CD90, CD105, CD45,
and HLA-DR [1].
2.2. Adipose Derived StemCells (ASCs; Purchased fromZenBio
Company, USA). Six samples of ASCs (𝑛 = 6), mesenchymal
stem cells of adipose tissue origin, used as control, were also
cultured in the same conditions, in early passages (1–5), in
order to compare them to GSC. When reaching 70–80% of
confluence, they were collected and frozen at −80∘C for RNA
extraction.
2.3. Osteoinduction. GSC (𝑛 = 8) and ASC (𝑛 = 6)
were cultured in 6-well plates. When attempting 70 to 80%
of confluence, osteogenic differentiation was induced by
DMEM-LG supplemented with 20% of FCS, 10mL/L of
Penicillin-Streptomycin (5UI/mL), 1% of NEAA, 2.5mg/L
of Amphotericin B (250 𝜇g/mL), adding to 50 𝜇g/mL of
L-Ascorbic Acid 2-Phosphate, 100 nM of dexamethasone,
and 10mM of 𝛽-glycerophosphate [19]. Culture media were
changed every 72 hours, by adding L-Ascorbic Acid 2-
Phosphate. Dexamethasone was supplemented every 7 days.
After 21 days, differentiated GSC (dGSC) and ASC were
either harvested after Trypsin-EDTA treatment and centrifu-
gation, frozen at −80∘C for RNA extraction, or fixed in PFA
4%/Sucrose 5% and conserved at 4∘C for staining.
2.4. Histochemical Staining. To confirmosteoinduction, fixed
cells were washed with phosphate-buffered saline (PBS,
Gibco), followed by two distilled water rinses and incubation
in fresh Alizarin Red S solution (1 g/100mL in distilled water,
Sigma-Aldrich), pH around 4.10, for 30min. The wells were
then rinsed repeatedly with distilled water, and calcium
deposits were observed (Figure 1).
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Figure 1: (a), (b), (c), and (d) Alizarin Red S Staining of GSC and ASC after 21 days of osteoblast induction. (a) and (b) GSC and ASC were
cultured in proliferation medium. No differentiation is noticed. (c) and (d) GSC and ASC were cultured in osteogenic medium. Calcium
mineral deposits confirmed osteoblast differentiation in both stem cells after 21 days of culture. Bar scale = 100𝜇m. (e) Colony forming units
for GSCs. Limiting dilution of GSCs shows their ability to form colonies after 5 days of culture. (f) Agarose gel electrophoresis: total RNA
quality. All RNA samples showed absence of degradation and a high degree of integrity. Upper bands: 28S, lower bands: 18S, and lanes 1 to 4:
random RNA samples from GSC and ASC.
2.5. Total RNA Extraction and cDNA Synthesis. Total RNA
was isolated (GSC 𝑛 = 8, ASC 𝑛 = 6, and differentiated
GSC 𝑛 = 8), using ReliaPrep RNA Cell Miniprep System
kit (Promega), according to manufacturer’s instructions.
This kit fits cell culture and incorporates a recombinant
DNase treatment step. RNA concentrations and purity were
assessed by a NanoDrop spectrophotometer (Thermo Sci-
entific, Wilmington, DE, USA). The purity was determined
by measuring the absorbance at 260 nm/280 nm. The ratio
𝐴
260
/𝐴
280
is expected to be between 1.8 and 2.0. RNA quality
was also confirmed by agarose gel electrophoresis, choosing 4
random samples, which confirmed the absence of ribosomal
RNA degradation, with a 28S/18S ratio around 2 (Figure 1(f)).
2𝜇g of RNAof each samplewas reverse-transcribed using
SuperScript II Reverse Transcriptase (Invitrogen) initiated by
random primers and oligo-dT primers, as described in the
provided protocol.The final volume was 20𝜇L.The latter was
20-fold diluted (v/v) to have the same final concentration of
5 ng/𝜇L of cDNA. Reactions were also prepared without the
reverse transcriptase enzyme, which gave minus RT products
to confirm the absence of genomic DNA contamination in
qPCR reactions.
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Table 1: 10 candidate housekeeping genes analysed.
Gene
symbol Gene name
Gene accession
number Primer sequence (F/R) 𝐸 (%)
Amplicon
size (bp)
TBP TATA box binding protein NM 003194.4 F: CAC GAA CCA CGG CAC TGA TT 94,2 88
R: TTT TCT TGC TGC CAG TCT GGA
C
SDHA Succinate dehydrogenasecomplex, subunit A, flavoprotein NM 004168.3
F: AGC AAG CTC TAT GGA GAC CT 88,4 199
R: TAA TCG TAC TCA TCA ATC CG
HPRT1 Hypoxanthinephosphoribosyltransferase I NM 000194.2
F: TGT TGG ATT TGA AAT TCC AGA
CAA G 90,5 107
R: CTT TTC CAG TTT CAC TAA TGA
CAC AA
GAPDH Glyceraldehyde-3-phosphatedehydrogenase NM 002046.5
F: CTT TGT CAA GCT CAT TTC CTG
GTA 82,5 70
R: GGC CAT GAG GTC CAC CA
RPS18 Ribosomal protein S18 NM 022551.2 F: AGC TTG TTG TCC AGA CCA TT 86,7 188
R: TGA GGA AAG CAG ACA TTG AC
ALAS1 5󸀠-Aminolevulinate synthase 1 NM 000688.5 F: AAC TTC CCA AAA TCT GTT TC 88,8 158
R: GGT GAT GAG GGA GTC TGA AT
ACTB Actin, beta NM 001101.3 F: CTG TGG CAT CCA CGA AAC 96 88
R: CAG ACA GCA CTG TGT TGG
B2M Beta-2-microglobulin NM 004048.2 F: CAG CAT CAT GGA GGT TTG AA 92 178
R: TGG AGA CAG CAC TCA AAG TA
UBC Ubiquitin C NM 021009.6 F: GTG GCA CAG CTA GTT CCG T 103 96
R: CTT CAC GAA GAT CTG CAT TGT
CA
RPII 50S ribosomal protein L9 NM 031420.3 F: CTT CAC GGT GCT GGG CAT T 95 240
R: GTG CGG CTG CTT CCA TAA
2.6. Selection of Reference Genes. Primer sequences for the 10
candidate housekeeping genes in the study of human stem
cells, TBP, SDHA, HPRT1, GAPDH, ALAS1, ACTIN, RPS18,
RPII, UBC, and B2M, were obtained fromNCBI primer-blast
tool, USA (Table 1). They were selected with an amplicon
size<250 bp, spanning an exon–exon junctionwhen possible,
with no polymorphism, and the idealmelting temperature𝑇
𝑚
was 60∘C (with a maximum difference of 3∘C between every
two primers). For primer nucleotides, they should end with a
C or G residue, and CG content was ranged between 50 and
60%. The cycle threshold (Ct) was ranged from 15 to 30. The
same tool and settings were used to generate the primers for
the analysis of stem cells osteogenic differentiation, such as
RUNX2.
2.7. RT q-PCR Assay. The assay was carried out in triplicate
in a 96-well format in the Bio-Rad CFX96 Real Time System
(Bio-Rad Laboratories, USA).The reaction volumewas 15 𝜇L.
For each sample, the real-time PCR mixtures consisted of
3 𝜇L cDNA (≈15 ng of cDNA) and 12 𝜇L ofmixture of 7.5𝜇L of
SYBRGreen Supermix (Bio-Rad), 0.45 𝜇L of primer (250 nM
final of each sense and antisense sequence of the primer),
and 4.05 𝜇L of RNase/DNase-free sterile water. The assay
included negative controls (nuclease-free water) and controls
with minus RT to detect reagent contamination and the
presence of genomic DNA, respectively. In order to define the
efficiency (𝐸) of each primer, serial dilutions (five dilutions:
from half to five times alternately) of one GSC sample which
expresses the genes of interest and the housekeeping genes
and relative standard curves were generated. Efficiency 𝐸was
calculated as follows: PCR efficiency = (10[−1/slope] − 1) × 100.
The reactions were run for 35 cycles following this
thermal cycling profile: (1) 95∘C for 3min, (2) denaturation
at 95∘C for 5 sec, (3) primer annealing step at 60∘C for 20 sec
(the most optimal temperature for all primer pairs after
performing preliminary real-time RT q-PCR assays).
To confirm primer specificity, a melting curve analysis
was performed after each amplification, ranging from 65∘C to
95∘C, with temperature increasing steps of 0.5∘C every 5 sec.
In all negative samples, no fluorescent signal was detected,
or at very late cycle (more than 10 cycles after the Ct). This
ensured of the quality of RNA extraction in all the samples.
2.8. Analysis of Gene Expression. In order to assess the
most stable reference genes to study GSC, ASC, and dGSC,
Ct of all samples were calculated (Figures 2(c), 2(d), and
2(e)). Ct is defined as the number of cycles needed for
the fluorescence signal to reach a specific threshold of
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Figure 2: PCR reaction values and expression levels of the 10 candidate reference genes. (a) Melt peak temperature was determined for each
reference gene to confirm the specificity of each primer. (b) Threshold values were manually set for each reference gene to calculate cycle
threshold (Ct) values. (c), (d), and (e) Expression levels (Ct values) were determined for all reference genes throughout all the samples: (c)
GSCs (𝑛 = 8), (d) dGSCs (𝑛 = 8), and (e) ASCs (𝑛 = 6).The central bars correspond to themean Ct values; the upper and lower bars represent
the standard deviation. These values were used in ΔCt and BestKeeper algorithms.
detection and is therefore reversely correlated to the input
amount of total RNA [20]. These values were used in ΔCt
and BestKeeper algorithms. Values of relative gene expres-
sion or normalized values (𝑅) were also calculated for use
in GeNorm and NormFinder analyses (see Supplementary
Material 1 in Supplementary Material available online at
http://dx.doi.org/10.1155/2016/6261490). For each HKG, Ct
values were logarithmically transformed for all the samples;
the lowest Ct was used as a calibrator against which change
is given. For each sample, ΔCt (the subtraction of cycle
threshold between the studied sample and the calibrator) is
calculated.The investigators use the efficiency (𝐸HKG) of each
primer, and the formula is the following:
The normalized value (𝑅) : 𝑅
= 𝐸HKG
ΔCt(Calibrator sample−studied sample)
.
(1)
2.8.1. The ΔCt Comparative Method. This approach is based
on the comparison of Ct differences, or ΔCt values of each
“pairs of genes” within each sample. The objective is to
determine if the reference gene has an increased or decreased
level of deviation in ΔCt among the samples when compared
to the other reference genes. If the ΔCt remains stable when
analyzed in different samples, it means that these two genes
are stably expressed all among the samples or that they are
coregulated [13]. ΔCt mean is calculated for each pair of
genes and between every two groups of HKGs. All genes are
taken into account and all possible “gene combinations” are
compared. Then, the standard deviation values of each ΔCt
set of each pair of genes is determined.
Reference genes are ranked according to the arithmetic
mean of standard deviation values, which must be as low as
possible to be the most stable. Box-and-whiskers charts can
also be generated to show the distribution of ΔCt values in
each pair of genes in the samples and allow us to compare
ΔCt variability of each reference gene against all others. The
bar is a line which represents the median (middle of dataset).
The 75 and 25 percentiles represent the upper and lower limits
of the boxes, and the whiskers refer to the highest and lowest
ΔCt values among the samples excluding outsiders.TheHKG
with the lowest variability is the most stable [21].
2.8.2. GeNorm Analysis. This method determines, among
set of candidate genes, the two most stable ones that share
a similar expression profile throughout all studied samples
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[22]. For each two candidate genes (gene 𝑗 and gene 𝑘), using
normalized values (𝑅, here 𝑎), the algorithm calculates the
array of log
2
transformed expression ratios and the standard
deviation 𝑉 of the pairwise variation of this gene toward all
other genes, as shown in the following formula:
𝐴
𝑗𝑘
= {log
2
(
𝑎
1𝑗
𝑎
1𝑘
) , log
2
(
𝑎
2𝑗
𝑎
2𝑘
) , . . . , log
2
(
𝑎
𝑚𝑗
𝑎
𝑚𝑘
)}
= {log
2
(
𝑎
𝑖𝑗
𝑎
𝑖𝑘
)}
𝑖=1→𝑚
,
𝑉
𝑗𝑘
= st.dev (𝐴
𝑗𝑘
) ,
(2)
where𝐴
𝑗𝑘
is array of pairwise variation of normalized values
of gene j toward gene k for all samples; 𝑉
𝑗𝑘
is standard
deviation of 𝐴
𝑗𝑘
values for gene j toward gene 𝑘.
Then the stability value (𝑀), defined as the average or
arithmetic mean of the standard deviations of this gene, is
calculated [14]:
𝑀
𝑗
=
∑
𝑛
𝑘=1
𝑉
𝑗𝑘
𝑛 − 1
. (3)
The algorithm ranks HKGs toward their𝑀 values, from the
most stable with the lowest𝑀 to the least stable. If𝑀 value
is more than 1.5, the gene is considered not stable and is
removed from the analysis. GeNorm recalculates, hence, 𝑀
values for the remaining stable genes and ranks reference
genes from the most stable to the least stable one. Stepwise
exclusion of the least stable genewith the highest𝑀 valuewill
ultimately result in the two most stable genes that cannot be
further ranked and selected a pair of genes as the most stable.
The other genes are hence ranked based on their highest
compatibility with𝑀 of the first pair [14].
In order to define accurately the number of HKGs needed
for the normalization, GeNorm proposes a second step of
calculation of the normalization factor, which is the variation
between each pair of genes consecutively ranked from the
most to the least stable. If the values are smaller than 0.15,
there is no need to add a new HKG. An Excel Add-In
method is available to make GeNorm analysis and graphs
excel, http://medgen.ugent.be/∼jvdesomp/genorm/.
2.8.3. BestKeeper Analysis. Unlike ΔCt comparative method
and GeNorm software, BestKeeper considers not only “inter-
gene” relation, but takes also into account the “intragene”
variation, which assesses samples variation in the same gene.
In this approach, the ideal HKGs are expected to have a stable
expression in the same tissue or sample [12]. For this, standard
deviation (SD: ±Ct) and covariance (CV: %Ct) are the two
important values to assess HKG stability. For a studied
reference gene, SD of Ct values must be as low as possible and
must not be >1; otherwise it will be excluded. A second step
consists of studying the correlationwithBestKeeper index and
selecting themost correlated reference gene to this index.The
tool simulates an ideal HKG, or the “best” HKG, for which it
calculates, for each sample, a BestKeeper index defined as the
geometric mean of Ct values of all HKGs for this sample, as
shown in the following formula:
𝐵𝑒𝑠𝑡𝐾𝑒𝑒𝑝𝑒𝑟 𝐼𝑛𝑑𝑒𝑥 =
𝑧
√CP1 × CP2 × CP3 × ⋅ ⋅ ⋅
× CP𝑧;
(4)
see [23].
Then it compares this index to each reference gene by a
pairwise correlation and regression analyses and calculates
a coefficient of correlation (𝑟) and the probability 𝑝. “𝑟”
should be as close to 1 as possible and “𝑝” as low as
possible. The BestKeeper index can also be compared to a
further ten genes, for the same samples, to decide whether
they are differentially expressed. Moreover, this algorithm
calculates invariances, InVar (±Ct), of each sample to validate
its stability; these values must be <3-fold the least one. A
freely Excel based spreadsheet software exists and allows us
to calculate automatically these values to make the choice
of the most stable HKGs easier. It has been established that
sample size has a minimal effect on this tool [23], http://www
.gene-quantification.de/bestkeeper.html#download.
2.8.4. NormFinder Analysis. This model takes into account
the influence of variation of gene expression in the same
sample and coregulation between different individuals [11].
For each candidate gene, the algorithm calculates a stability
value 𝑝, taking into account the intra- and intergroup
variances. The reference gene which has the smallest 𝑝 value
is ranked as the most stable, as it has the smallest variation
over all samples. By creating subgroups, the algorithm can
also select the most appropriate candidate genes to study two
groups of samples, choosing the ones with the minimal intra-
and intergroup variations. Intragroup variation must be as
small as possible, and intergroup variation ≈ 0. The results
are affected by the number of samples and are more accurate
when 𝑛 increases (𝑛 ≥ 8). It also requires at least 5 to 10HKGs.
In order to compare the 4 algorithms and select the
most stableHKGs,we appliedRefFinder (http://www.leonxie
.com/referencegene.php), a web-based comprehensive tool,
which uses the currently available algorithms, ΔCt com-
parative methods [13], GeNorm [14], BestKeeper [12], and
NormFinder [11], and assigns an appropriate weight to an
individual gene and calculates the geometric mean in order
to rank all the studied reference genes.
3. Results
3.1. GSC Osteogenic Induction and RNA Quality Control.
Eight GSC samples were obtained from healthy patients dur-
ing surgical treatment. Six samples of ASCs were purchased
and cultured in the same conditions. Both GSCs and ASCs
were induced into osteogenic differentiation in duplicate for
21 days. Cellularmatrix in proliferationmediumwas negative
to the Alizarin Red S staining (Figures 1(a) and 1(b)). Mineral
nodules and matrix were present in osteogenic medium and
confirmed with this histochemical staining for both stem
cells (Figures 1(c) and 1(d)). This stresses that GSCs are
capable of osteogenic differentiation in vitro like ASCs, which
Stem Cells International 7
Table 2: The 4 algorithms used in the study.
Analysis method PCR values Stability values Type of analysis
The ΔCt comparative method Ct StdDev mean Intergene
GeNorm 𝑅 𝑀, NF
Intergene
One HKG → all other HKGs
Stable HKGs: lowest variability: low𝑀
BestKeeper Ct SD, 𝑟
Intra- and intergene
Pairwise correlation analysis → BestKeeper index
Stable HKGs: low SD and high 𝑟
NormFinder 𝑅 𝜌 Intra- and intergene; stable HKGs: least intra- andintergroup variations
are already known to form minerals in vitro under these
conditions of culture. GSCs were CD29+, CD73+, CD90+,
CD105+, CD45−, and HLA-DR− by flow cytometry analysis
(data not shown) and formCFU-F (Figure 1(e)). RNA of both
GSC and ASC was collected, with a yield of more than 1 𝜇g.
The analyses of puritywith theNanoDrop spectrophotometer
showed suitable ratios 𝐴
260
/𝐴
280
with values around 2.00.
RNA quality was confirmed randomly for 4 samples of
GSCs and ASCs by agarose gel electrophoresis, insuring the
integrity of ribosomal RNA, with two bands of 18S and 28S
(Figure 1(f)).
3.2. The Choice of the Most Reliable HKGs for GSCs,
dGSCs, and ASCs. In order to select the most appropri-
ate and stable HKGs to study GSC and their osteogenic
differentiation, expression of ten reference genes chosen
according to previous published studies [15, 23, 24] was
assessed. These reference genes were TBP (TATA-binding
protein), SDHA (succinate dehydrogenase complex, subunit
A, flavoprotein), HPRT1 (hypoxanthine guanine phospho-
ribosyltransferase I), GAPDH (glyceraldehyde-3-phosphate
dehydrogenase), RPS18 (40S ribosomal protein S18), ALAS1
(5-Aminolaevulinate synthase),ACTB (Beta-actin (𝛽-actin)),
B2M (Beta-2-microglobulin), UBC (Ubiquitin C), and RPII
(50S ribosomal protein L9). Gene information are available
and primer’s efficiencies were between 82.5% and 103%
(Table 1).
RT-qPCR were performed for 35 cycles in GSC samples
(𝑛 = 8), GSCs after osteogenic induction (referred to as
differentiated GSCs: dGSC) (𝑛 = 8), and compared to ASCs
(𝑛 = 6). A melting curve analysis showed a single product
at the expected melt temperature for each reference gene
(Figure 2(a)). Results were analysed with a logarithmic scale
and a threshold level wasmanually selected for each reference
gene to detect the expression levels as cycle threshold (Ct)
values for all samples (Figure 2(b)). Ct values were collected
for each group of samples (Figures 2(c), 2(d), and 2(e)).
In all samples, GAPDH, RPS18, B2M, and ACTB had Ct
values below 20 cycles and hence had an early expression,
unlike SDHA, TBP, HPRT1, ALAS1, UBC, and RPII that had
lowest expression values. The normalized values (𝑅): 𝑅 =
𝐸HKG
ΔCt(Calibrator sample−studied sample) were calculated for each
sample usingCt values (SupplementaryMaterial 1). Datawere
treatedwith four algorithms: theΔCt comparativemethod [13]
and GeNorm [14] for inter-gene relation, BestKeeper [12] and
NormFinder [11] for intra- and intergene correlation (Table 2).
3.3. The ΔCt Comparative Method. This method is based on
comparing the variability of expression levels of each “pair
of genes” within all the samples, in order to identify the
reference gene with the lowest variability to be ranked as
the most stable. The method was applied in each group of
samples separately: GSCs, dGSCs, and ASCs. For each pair
of genes, ΔCt values were calculated in all the samples, as
well as the 󳵻Ct mean and the standard deviations (StdDevs)
of ΔCt values (for GSCs, Table 3; for ASCs and dGSCs,
Supplementary Material 2). The arithmetic mean of StdDevs
was then identified for each reference gene and HKGs were
ranked according to these values. This is shown in box-
and-whiskers charts with all possibilities for all the 10HKGs
(Figures 3(a), 3(b), and 3(c)). In GSC samples, SDHA, ACTB,
and B2M were the most stable genes (StdDev mean = 0.97,
0.98, and 0.98, resp.). HPRT1 and RPII were the least stable
and had a higher variability within the samples (StdDevmean
= 1.38 and 1.64, resp.). In dGSCs, TBP, SDHA, and ALAS1
showed the lowest variability in the samples as compared
to the other genes, with a StdDev mean of 0.69, 0.72, and
0.78, respectively, whereas GAPDH and RPS18 showed the
highest variability. In ASCs, the most stable genes were
SDHA,HPRT1, andTBP, with the lowest StdDevmeans (0.66,
0.71, and 0.77, resp.), while ALAS1 and ACTB were the least
stable ones.
Finally, the intergene analysis by ΔCt comparative
method ended with a recommendation to normalize GSCs
data using SDHA, ACTB, and B2M, dGSCs with TBP, SDHA,
and ALAS1, and ASCs with SDHA, HPRT1, and TBP.
3.4. GeNorm Analysis. Normalized expression values of each
group: GSCs, dGSCs, and ASCs were entered in the Excel
spreadsheet under the format recommended by the authors,
respectively [14].
Firstly, the stability value𝑀 was calculated for all HKGs,
and reference genes were ranked from the most stable, with
the lowest 𝑀 values, to the least stable ones, as shown in
Table 4. Graphs were generated showing the average expres-
sion stability𝑀 values, selecting themost stable pair of genes,
according to which it ranks the other genes (Figure 4(a)).
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Table 3: The ΔCt comparative method analysis for GSCs.
Gene versus gene Mean ΔCt StdDev Mean StdDev Gene versus Gene Mean ΔCt StdDev Mean StdDev
TBP versus SDHA 3,73 0,84
1.05
ALAS1 versus TBP 0,56 1,51
1.27
TBP versus HPRT1 1,85 0,86 ALAS1 versus SDHA −3,18 1,02
TBP versus GAPDH 8,48 0,92 ALAS1 versus HPRT1 −1,30 1,87
TBP versus RPS18 8,99 1,00 ALAS1 versus GAPDH −7,93 1,27
TBP versus ALAS1 0,56 1,51 ALAS1 versus RPS18 −8,43 1,37
TBP versus ACTB 8,67 0,85 ALAS1 versus ACTB 8,12 1,20
TBP versus B2M 9,29 0,88 ALAS1 versus B2M 8,73 0,99
TBP versus UBC −1,68 0,64 ALAS1 versus UBC −2,24 1,36
TBP versus RPII 0,99 1,99 ALAS1 versus RPII 0,43 0,85
SDHA versus TBP 3,73 0,84
0.97
ACTB versus TBP 8,67 0,85
0.98
SDHA versus HPRT1 −1,88 1,36 ACTB versus SDHA 4,94 0,63
SDHA versus GAPDH 4,75 0,75 ACTB versus HPRT1 6,82 1,01
SDHA versus RPS18 5,25 1,00 ACTB versus GAPDH 0,19 0,93
SDHA versus ALAS1 −3,18 1,02 ACTB versus RPS18 −0,31 1,18
SDHA versus ACTB 4,94 0,63 ACTB versus ALAS1 8,12 1,20
SDHA versus B2M 5,56 0,90 ACTB versus B2M 0,62 0,83
SDHA versus UBC −5,41 0,89 ACTB versus UBC −10,35 0,67
SDHA versus RPII −2,75 1,33 ACTB versus RPII −7,69 1,54
HPRT1 versus TBP 1,85 0,86
1.37
B2M versus TBP 9,29 0,88
0.98
HPRT1 versus SDHA −1,88 1,36 B2M versus SDHA 5,56 0,90
HPRT1 versus GAPDH 6,63 1,42 B2M versus HPRT1 7,44 1,27
HPRT1 versus RPS18 7,13 1,23 B2M versus GAPDH 0,81 0,72
HPRT1 versus ALAS1 −1,30 1,87 B2M versus RPS18 0,30 1,09
HPRT1 versus ACTB 6,82 1,01 B2M versus ALAS1 8,73 0,99
HPRT1 versus B2M 7,44 1,27 B2M versus ACTB 0,62 0,83
HPRT1 versus UBC −3,53 1,03 B2M versus UBC −10,97 0,70
HPRT1 versus RPII −0,87 2,41 B2M versus RPII −8,30 1,47
GAPDH versus TBP 8,48 0,92
1.06
UBC versus TBP −1,68 0,64
1.02
GAPDH versus SDHA 4,75 0,75 UBC versus SDHA −5,41 0,89
GAPDH versus HPRT1 6,63 1,42 UBC versus HPRT1 −3,53 1,03
GAPDH versus RSP18 0,50 1,16 UBC versus GAPDH −10,16 0,86
GAPDH versus ALAS1 −7,93 1,27 UBC versus RPS18 −10,66 1,39
GAPDH versus ACTB 0,19 0,93 UBC versus ALAS1 −2,24 1,36
GAPDH versus B2M 0,81 0,72 UBC versus ACTB −10,35 0,67
GAPDH versus UBC −10,16 0,86 UBC versus B2M −10,97 0,70
GAPDH versus RPII −7,50 1,54 UBC versus RPII 2,67 1,68
RPS18 versus TBP 8,99 1,00
1.27
RPII versus TBP 0,99 1,99
1.64
RPS18 versus SDHA 5,25 1,00 RPII versus SDHA −2,75 1,33
RPS18 versus HPRT1 7,13 1,23 RPII versus HPRT1 −0,87 2,41
RPS18 versus GAPDH 0,50 1,16 RPII versus GAPDH −7,50 1,54
RPS18 versus ALAS1 −8,43 1,37 RPII versus RPS18 −8,00 2,00
RPS18 versus ACTIN −0,31 1,18 RPII versus ALAS1 0,43 0,85
RPS18 versus B2M 0,30 1,09 RPII versus ACTB −7,69 1,54
RPS18 versus UBC −10,66 1,39 RPII versus B2M −8,30 1,47
RPS18 versus RPII −8,00 2,00 RPII versus UBC 2,67 1,68
For GSCs (𝑛 = 8), the most stable genes were SDHA,
B2M, and ACTB, (𝑀 = 0.892, 0.919, and 0.924, resp.). RPII
was the least stable (𝑀 = 1.588) and excluded from analysis
(𝑀 > 1.5). Hence, RPS 18 and ALAS1 were the least stable
(𝑀 = 1.162, 1.163, resp.). SDHA and ACTB were selected as
themost stable pair of genes (Figure 4(a1)). Regarding dGSCs
(𝑛 = 8), TBP, SDHA, ALAS1, and RPII were the most stable
with 𝑀 values, 0.656, 0.677, 0.729, and 0.771, respectively.
UBC and RPS18 had the highest𝑀 values (𝑀 = 0.858; 0.925)
and were considered the least stable genes. TBP and ALAS1
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Table 4: GeNorm analysis.
Rank GSCs (𝑛 = 8) dGSCs (𝑛 = 8) ASCs (𝑛 = 6)
Gene 𝑀 values Gene 𝑀 values Gene 𝑀 values
1 SDHA 0.892 TBP 0.656 SDHA 0.619
2 B2M 0.919 SDHA 0.677 HPRT1 0.656
3 ACTB 0.924 ALAS1 0.729 TBP 0.717
4 UBC 0.964 RPII 0.771 RPS18 0.741
5 GAPDH 0.968 B2M 0.777 UBC 0.778
6 TBP 0.985 ACTB 0.729 GAPDH 0.786
7 HPRT1 1.294 GAPDH 0.849 B2M 0.806
8 RPS18 1.162 HPRT1 0.849 RPII 0.997
9 ALAS1 1.163 UBC 0.858 ALAS1 1.081
10 RPII 1.588 RPS18 0.925 ACTB 1.491
were thus selected as the best pair of genes (Figure 4(a2)).
As for ASCs (𝑛 = 6), SDHA, HPRT1, and TBP were the
most stable (𝑀 = 0.619, 0.656, and 0.717, resp.). ALAS1 and
ACTB were the least stable (𝑀 = 1,081; 1,491). GAPDH and
B2M were the optimal pair of genes according to the software
(Figure 4(a3)).
Pairwise variation analysis by calculating two sequential
normalization factors (NF
𝑛
and NF
𝑛+1
) suggested that the
optimal number of reference genes to study teach group of
stem cells was threeHKGs for GSCs and dGSCs (𝑉
3/4
= 0.165
for both of them, which is around 0.15 as suggested by the
software) (Figures 4(b1) and 4(b2)) and two reference genes
for ASCs (𝑉
2/3
= 0.134 below 0.15) (Figure 4(b3)).
Finally, the intergene analysis by GeNorm recommended
SDHA/ACTB and UBC to study GSCs, TBP/ALAS1 and
SDHA for dGSCs, and GAPDH/B2M or SDHA/HPRT1 to
study ASCs (Table 4).
3.5. BestKeeper Analysis. Raw Ct values of each group (GSCs
(𝑛 = 8), dGSCs (𝑛 = 8), and ASCs (𝑛 = 6)) were uploaded
to BestKeeper software in the form of an Excel spreadsheet.
Firstly, BestKeeper excluded candidate HKGs with highest
standard deviation (SD) and the covariance (CV). For GSCs,
RPII and ALAS1 had the highest SD (1.66, 1.31) and CV
(6.99, 5.18), respectively, and were therefore excluded from
analysis. Using pairwise correlation analysis and regression
analysis, BestKeeper then compared the intergene relations of
remaining candidate genes based on its index. UBC, HPRT1,
TBP, and RPS18 had a low correlation with BestKeeper index
(𝑟 = 0.685, −0.050, 0.622, and 0.684, resp.) and thus were
also excluded from analysis, even though they may have low
SD and CV likeUBC,HPRT1, and TBP (Figure 5(a)). Among
the remaining genes, SDHA had the lowest variation (SD =
0.79, CV = 3.55) and the best correlation with BestKeeper
index (𝑟 = 0.938, 𝑝 < 0.001) followed by B2M (𝑟 = 0.861,
𝑝 < 0.006), ACTB (𝑟 = 0.841, 𝑝 < 0.007), and GAPDH
(𝑟 = 0.799, 𝑝 < 0.017) as summarized in Table 5(a).
For dGSCs (𝑛 = 8), all HKGs had low variances, with the
least variability for TBP (SD = 0.37, CV = 1.40) andACTB (SD
= 0.46, CV = 2.48) and the highest variability for RPII (SD
= 0.79, CV = 3.27) and UBC (SD = 0.80, CV = 2.92). Then
the correlation with BestKeeper index excluded GAPDH (𝑟 =
Table 5: BestKeeper correlation analysis.
(a)
GSCs (𝑛 = 8) SDHA B2M ALAS1 RPII ACTB GAPDH
Coefficient of
correlation
(𝑟)
0.938 0.861 0.894 0.886 0.841 0.799
𝑝 value 0.001 0.006 0.003 0.003 0.007 0.017
(b)
dGSCs
(𝑛 = 8) RPII B2M SDHA UBC HPRT1 TBP
Coefficient of
correlation
(𝑟)
0.900 0.823 0.812 0.810 0.776 0.752
𝑝 value 0.002 0.012 0.014 0.015 0.024 0.031
(c)
ASCs (𝑛 = 6) HPRT1 SDHA RPS18 RPII
Coefficient of
correlation
(𝑟)
0.914 0.893 0.864 0.813
𝑝 value 0.011 0.017 0.027 0.049
0.335), RPS18 (𝑟 = 0.336), ACTB (𝑟 = 0.540), and ALAS1 (𝑟 =
0.731). Gene ranking from the most correlated was B2M (𝑟 =
0.823, 𝑝 < 0.012), SDHA (𝑟 = 0.812, 𝑝 < 0.014), HPRT1 (𝑟 =
0.776, 𝑝 < 0.024), and TBP (𝑟 = 0.752, 𝑝 < 0.031). RPII and
UBC had a high correlation with BestKeeper index (𝑟 = 0.900,
𝑝 < 0.002 and 𝑟 = 0.810, 𝑝 < 0.015, resp.); however, they
were the least stable, as shown formerly with the highest SD
and CV values (Figure 5(b)). Consequently, the final ranking
was B2M, SDHA, HPRT1, and TBP (Table 5(b)).
For ASCs (𝑛 = 6), ALAS 1 was first excluded (SD =
1.01, CV = 4.23). Then, the correlation with BestKeeper index
showed a low 𝑟 for ACTB (𝑟 = −0.142), GAPDH (𝑟 =
0.291), B2M (𝑟 = 0.458), and UBC (𝑟 = 0.486), which were
also excluded (Figure 5(c)). The most correlated HKGs with
BestKeeper index were HPRT1 (𝑟 = 0.914; 𝑝 < 0.011), SDHA
(𝑟 = 0.893; 𝑝 < 0.017), RPS18 (𝑟 = 0.864; 𝑝 < 0.027), and
RPII (𝑟 = 0.813; 𝑝 < 0.049) as shown in Table 5(c).
Based on these results, the most reliable HKGs with
BestKeeper software were SDHA, B2M, and ACTB for GSCs,
B2M and SDHA for dGSCs, and HPRT1, SDHA, and RPS18
for ASCs.
3.6. NormFinder Analysis. Normalized values of the three
groups were introduced into NormFinder software as recom-
mended by the authors [11]. The algorithm is presented as a
free complement in Excel program. The analysis calculates
the value of stability 𝜌 of each reference gene and ranks them
from the most stable with the lowest 𝜌 to the least stable.
For intragroup analysis,NormFinder ranked SDHA,B2M,
and ACTB as the most stable (𝜌 = 0.248, 0.300, and 0.317,
resp.) for GSCs. TBP, SDHA, andALAS1were the most stable
for dGSC (𝜌 = 0.222, 0.234, and 0.335, resp.), and SDHA,
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Figure 3: Ranking of 10HKG in GSC (a), dGSC (b), and ASC (c) with ΔCt comparative method. ΔCt variability with pairwise comparisons
of the complete set of candidate housekeeping genes shown as boxes and whiskers: medians (lines), 25th and 75th percentiles (Boxes). Genes
with lowest variability were the most stable.
TBP, and RPS18 for ASCs (𝜌 = 0.063, 0.224, and 0.246, resp.)
(Table 6).
Further analysis was realized in order to select the most
appropriate reference genes to compare gene expression of
GSCs to dGSCs and to ASCs. For this purpose, two pairs
of subgroups were created: GSCs versus dGSCs and GSCs
versus ASCs. NormFinder calculated intra- and intergroup
variances, as shown in charts in which error bars presented
intragroup variances and bars referred to intergroup vari-
ances (Figures 6(a) and 6(b)).
As for GSCs versus dGSCs, although ALAS1 and UBC
displayed low intergroup variances, ALAS1 had a high intra-
group variance inGSCs andUBC in dGSC, hence not suitable
for the study (Figure 6(a)). RPII had the highest intergroup
variance in GSCs and dGSCs and also the highest intragroup
variance inGSCs; this gene was then ranked as the least stable
one. SDHA and ACTB were selected by the algorithm as the
most suitable to compare GSCs to dGSCs, with the lowest
intergroup variances and intragroup variances close to zero.
Concerning GSCs versus ASCs, GAPDH and RPS18 had
low intervariances, but their intragroup variances were high:
GAPDH in both GSCs and ASCs and RPS18 in GSCs.
Hence, they were not the most stable genes to study these
subgroups. RPII had the highest intergroup variance and
was the least stable gene. SDHA and B2M had the lowest
intergroup variances and were also stable inside each group,
with the lowest intragroup variances. Consequently, they
were selected to compare gene expression between GSCs and
ASCs.
Thus, NormFinder allowed us to confirm gene ranking
of GeNorm for the three groups of samples, GSCs, dGSCs,
and ASCs and, moreover, enabled us to select the most
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Figure 4: Gene expression stability and minimal number of genes needed in (a) GSC (𝑛 = 8), (b) dGSC (𝑛 = 8), and (c) ASC (𝑛 = 6), by
GeNorm. ((a1), (a2), and (a3)) Average expression stability values (𝑀) for GSC, dGSC, and ASC. A lower𝑀 value indicated a more stable
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Figure 5: Ranking of the most stable HKGs with BestKeeper analysis for GSC (a), dGSC (b), and ASC (c). Bars represented the coefficient of
correlation 𝑟, while error bars represented the standard deviation (SD). Ideal reference gene had low SD and a high 𝑟. ∗𝑝 ≤ 0.05.
Table 6: NormFinder analysis.
Rank
GSCs (𝑛 = 8) dGSCs (𝑛 = 8) ASCs (𝑛 = 6)
Gene 𝜌 values Gene 𝜌 values Gene 𝜌 values
1 SDHA 0.248 TBP 0.222 SDHA 0.063
2 B2M 0.3 SDHA 0.234 TBP 0.224
3 ACTB 0.317 ALAS1 0.335 RPS18 0.246
4 UBC 0.388 RPII 0.364 UBC 0.257
5 GAPDH 0.401 B2M 0.380 GAPDH 0.42
6 TBP 0.453 ACTB 0.411 B2M 0.464
7 HPRT1 0.608 GAPDH 0.454 RPII 0.487
8 ALAS1 0.616 HPRT1 0.457 HPRT1 0.514
9 RPS18 0.78 UBC 0.472 ALAS1 0.671
10 RPII 1.025 RPS18 0.528 ACTB 1.1
appropriate genes to compareGSCs versus dGSCs: SDHA and
ACTB, and GSCs versus ASCs: SDHA and B2M.
3.7. Final Ranking ofHKGs forGSCs, dGSCs, andASCs. Based
on the four algorithms, an additional control was performed
with RefFinder, a tool that uses only Ct values and calculates
the geometric mean of overall ordering of all reference genes
and suggested a final ranking of themost stable housekeeping
genes. Results are summarized in Table 7.
3.8. Effect of the Choice of Stable HKGs. In order to validate
the importance of choosing the optimal reference genes to
normalize RT-qPCR data, two analyses of gene expression of
GSCs were performed based on the former results.
The first analysis compared four random samples of
GSC, GSC1, GSC3, GSC4, and GSC6, and their expression
of a target gene, Collagen 1 alpha 1 (COLL1A1). The relative
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Figure 6: Determination of the most stable reference genes with NormFinder For GSC versus dGSC (a) and GSC versus ASC (b). Bars
represent intergroup variances, while error bars represented the average of intragroup variances. Ideal reference gene had intergroup variation
as close to zero as possible and error bars as small as possible.
Table 7: Final ranking of HKGs.
Algorithm GSC dGSC ASC
ΔCt comparative method SDHA/ACTB/B2M TBP/SDHA/ALAS1 SDHA/HPRT1
GeNorm
SDHA/ACTB/UBC TBP/ALAS1/SDHA GAPDH/B2M
SDHA/B2M/ACTB TBP/SDHA/ALAS1 HPRT1/SDHA
3 genes 3 genes 2 genes
BestKeeper SDHA/B2M/ACTB B2M/SDHA/HPRT1 HPRT1/SDHA
NormFinder SDHA/B2M/ACTB TBP/SDHA/ALAS1 SDHA/TBP/RPS18
RefFinder UBC/ACTB/SDHA TBP/SDHA/ACTB HPRT1/SDHA
Selected genes SDHA/ACTB/B2M TBP/SDHA HPRT1/SDHA
fold expression with no normalization of this gene showed
differences between the four samples: GSC6 had the highest
relative fold expression (1.00 ± 0.028), followed by GSC3
(0.66 ± 0.001), GSC4 (0.38 ± 0.001), and GSC1 (0.11 ±
0.003). GSC3 had a 6-fold higher expression than GSC1
(Figure 7(a)). Data were then normalized with three groups
of genes: SDHA, ACTB, and B2M were the most stable genes
as suggested by our present study, GAPDH was the most
commonly used reference gene, and ALAS1 and RPS18 were
the least stable ones according to our results.
The normalization with SDHA, ACTB, and B2M showed
a different ranking: GSC3 (2.21 ± 0.021) had the highest
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Figure 7: Effect of the choice of stable HKGs in the study of four samples of GSC. The relative fold expression (a) and the normalized fold
expression of COLL1A1 of 4 samples of GSC. The normalization was performed with SDHA/B2M/ACTB, the most stable genes (b), GAPDH,
the most usually used (c), and ALAS1/RPII, the least stable genes (d). Error bars expressed the standard deviation of the mean.
normalized fold expression, followed by GSC4 (1.31±0.015),
GSC6 (1.09 ± 0.141), and GSC1 (0.62 ± 0.023). In this
ranking, GSC3 had a 3.5-fold higher expression than GSC1
(Figure 7(b)). When normalized with GAPDH, the ranking
was the same as the normalization with the stable HKGs, but
GSC3 (1.83 ± 0.020) had an 8.5-fold higher expression than
GSC1 (0.21 ± 0.014) (Figure 7(c)). At last, the normalization
with ALAS1 and RPII showed a different ranking, unlike
the former analyses, GSC1 (38.98 ± 0.295) had the highest
normalized expression, followed by GSC3 (5.02 ± 0.097),
GSC4 (1.37 ± 0.070), and GSC6 (1.01 ± 0.300). GSC1 had a
0.15-fold expression as compared to GSC3.
The second analysis was performed on samples of dGSCs
(𝑛 = 6) and compared to ASCs (𝑛 = 6) after osteogenic
differentiation. Expression level of RUNX2 was assessed on
different time points: day 0 (D0), day 7 (D7) and day
14 (D14) after osteogenic differentiation, confirmed by the
microscopic observation of mineral nodules formation and
Alizarin Red S staining (Supplementary Material 3). The
normalization was performed against the two most stable
reference genes and compared to the least stable one as shown
in Figure 8. For dGSCs, the normalization to SDHA and
TBP showed a significant increase of RUNX2 expression at
D7 and D14 when compared to the relative gene expression
(Figure 8(a)). When data were normalized with RPS18, the
least stable reference gene for dGSCs, there was a decrease
in the expression of RUNX2, with a statistically significant
difference when compared to SDHA and TBP. Concerning
ASCs, the normalization with SDHA and HPRT1 showed
also an increasing expression level of RUNX2 at D7 and
D14 and an insignificant increase at D7 of this target gene
when normalized with ACTB, the least stable reference gene
(Figure 8(b)).This confirms the importance and the dramatic
effect of the choice of suitableHKGs forGSCs before and after
osteogenic differentiation.
4. Discussion
This study was performed to confirm previously well-
recognized properties of GSCs [1] as well as their osteogenic
potential [2]. GSCsmight be an interesting tool in human cell
therapy and especially in bone regeneration of craniofacial
bones that share the same embryonic origin. Our study
compared human GSCs to adipose-derived mesenchymal
stem cells (ASCs), as they have been well studied in their
differentiation capacities, thoroughly highlighted in vitro and
in vivo [25]. The osteogenic differentiation capacity of GSCs
needs to be supported by q-PCR, whichmeasures the relative
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Figure 8: Effect of the choice of stable HKGs in the study of dGSC (𝑛 = 6) (a) and ASC (𝑛 = 6) (b). The normalization of fold expression of
an osteogenic marker, RUNX2, was performed on D0, D7, and D14. As calibrators: for dGSCs: TBP/SDHA the most stable HKGs and RPS18
the least stable one. For ASCs: SDHA/HPRT1 the most stable HKGs andACTB the least stable one. 𝑝 values have been obtained with unpaired
𝑡-test. ∗∗∗∗𝑝 ≤ 0.0001, ∗∗∗𝑝 ≤ 0.001, and ∗∗𝑝 ≤ 0.01 and “ns” stands for 𝑝 ≥ 0.05.
expression of genes implicated in osteogenic differentiation.
q-PCR is a very accuratemethod for gene expression analysis;
however, data analyses are often variable. This is due to
many factors linked to each step of the investigations, from
harvesting cells to cDNA synthesis.That is why q-PCR results
have to be normalized. The validation of stable and adequate
reference genes, to which data are normalized, is the most
commonly used method and may allow bypassing variability
factors. The choice of a reference gene must be accurate,
because any improper HKG may give false interpretation of
q-PCR results [26]. GAPDH is the most used reference gene,
but recent studies showed that this gene is not suitable for
all tissues or cell types or experimental settings [6]. An ideal
HKG is expected to have a constant level of expression in all
cell types, at all-time points, and under different experimental
conditions. Studies have been carried out to reach a “universal
HKG” in all species but, to our knowledge, not one was
found [13]. To solve this problem of choosing suitable HKGs,
many algorithms were generated by mathematicians and
statisticians in order to select accurately the most stable
reference genes.
In this work, we aimed to select the most appropriate
HKGs to study human GSCs and their osteogenic differen-
tiation in vitro in order to use them for clinical application.
10 reference genes were studied on GSCs, dGSCs, and ASCs
(mesenchymal stem cells, with known osteogenic capacity)
and analysed by four algorithms: ΔCt comparative method,
GeNorm, BestKeeper, and NormFinder.
Experiments were rigorously conducted to obtain com-
parable and reproducible results; a special attention was
given to prepare accurately with the same conditions growing
and differentiation media while culturing different stem
cells. The used RNA extraction kit was appropriate to cell
culture and the products were carefully used at the ade-
quate amount corresponding to cells number. RT q-PCR
reactions were performed according to the MIQE Guidelines
(Supplementary Material 4) [7]. Consequently, in our study,
despite a slight dissimilarity in the ranking of HKGs among
the four algorithms, results showed a highly homogenous
reproducibility; indeed, a similar tendency was found for the
three most stable genes and an overall comparable order of
genes.
ΔCt comparative method and GeNorm were used for
intergene study; ΔCt comparative method identifies the most
reliable reference gene as the one that varies the less when
compared to all the other genes among all the sample. This
method needs no high-level mathematical methodology and
is ideal for the nonspecialist to determine the best reference
genes [13]. GeNorm software not only defines the optimal
combination of genes or the ideal “pair of genes” with low
variability, but also proposes the minimal number of stable
HKGs. These two methods can be used if the amount of
the starting material of studied samples is not enough to
study many HKGs, because they are minimally affected by
expression intensity [23]. However, they do not take into
account coregulated genes and if used alone they may lead to
errors. These algorithms showed the same ranking of the ten
reference genes in the three groups. SDHA, ACTB, and B2M
were the most stable to study GSCs; TBP, SDHA, and ALAS1
for dGSCs; and SDHA, HPRT1, and TBP for ASCs.
For more accuracy, we used BestKeeper and NormFinder,
which study also intragene variability. BestKeeper is an
interesting tool, because it considers not only intra- and
intergroup variation, but also sample integrity. Our samples
seemed to have conserved their integrity when applying this
analysis throughout all the groups (22 samples of GSCs,
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dGSCs, and ASCs). NormFinder is considered to be an extra
control for GeNorm [22] because it uses a different algorithm
and relies on calculating the stability value for each HKG.
These two methods seem to be very sensitive to the size of
samples and to expression intensity. The ranking of stable
reference genes was the same as ΔCt comparative method
and GeNorm for GSCs but slightly different for dGSCs and
ASCs. BestKeeper ranked B2M, SDHA, and HPRT1 as the
most stable for dGSCs and HPRT1, SDHA, and RPS18 for
ASCs. The least stable genes were ranked differently than
ΔCt comparative method and GeNorm for the three groups of
samples.NormFinder ranking was less different from the two
precedent algorithms, and the only difference was noticed
on ASCs ranking. HPRT1 was ranked 8th rather than with
the three most stable reference genes. This can be due to
the decreased sample size of ASC (𝑛 = 6) which may affect
BestKeeper and NormFinder analyses.
Ideally, the ranking of stable HKGs must rely on the
results found by the four methods, because the reproducibil-
ity and accuracy increase, as the mathematical and statistical
bases are different. RefFinder by calculating the geometric
mean of overall ordering may help us to identify more easily
the stable reference genes; however, it does not take into
account q-PCR efficiencies of different primers and only uses
Ct values.
Finally, when we analysed each group of samples sepa-
rately, we found that SDHA, B2M, and ACTB were ranked as
the most stable for GSCs; TBP, SDHA, and ALAS1 for dGSCs;
and SDHA and HPRT1 for ASCs.
The analysis of gene expression for GSCs either differen-
tiated or not showed that the normalization with random ref-
erence genes leads to errors. Our results regarding osteogenic
differentiation of GSCs were in agreement with previous
publications; TBP was found as a suitable reference gene to
study osteogenic differentiation in stem cells [24]. Regardless
of the origin of stem cells and the stage of differentiation,
SDHA seems to be a good reference gene, as it was stable in all
conditions but is not enough alone to study GSC. Ribosomal
genes were the least stable, but they might be useful in other
conditions [21].
This present study provides methods to determine suit-
able reference genes. These tools are crucial to studying fur-
ther the GSC properties and compare the stem cell lineages.
Indeed, the osteogenic differentiation can be thoroughly
investigated under different conditions (conditioned media,
biomaterials, etc.) in order to use GSCs in human bone
regeneration.
5. Conclusion
Regardless of the algorithm used in this study, all of the
software used has ranked the same set of reference genes as
the most stable. Finally, based on our results, we recommend
the use of SDHA, B2M, and ACTB for GSCs; TBP, SDHA,
and ALAS1 for dGSCs; and SDHA and HPRT1 for ASCs
study. We stress on the importance to select the most suitable
HKGs before conducting a study of q-PCR of any stem cell
type.
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